Clinical evaluation of lamivudine therapy in patients with chronic hepatitis B based on a long-term outcome : Comparison with entecavir therapy
スポンサーリンク
概要
著者
関連論文
- A case with hepatitis C who displayed hyperthyroidism followed by hypothyroidism during the course of peg-interferon monotherapy: relevance to changes in thyroid autoantibodies titer
- 岩手県赤十字血液センターにおけるHBV genotype A献血者の臨床的、疫学的特徴
- Latent thyroid dysfunction in patients with chronic hepatitis C virus infection and its relevance to emergence of symptoms after peg-interferon treatment
- Analysis of the clinical etiology of non-alcoholic fatty liver disease : the state of adipocytokine dynamics and markers of insulin resistance and arteriosclerosis
- Clinical characteristics of individuals with elevated ALT level discovered by the medical screening in Iwate Prefecture : focusing on alcohol consumption and fatty liver disease
- Frequency of fatty liver in the medical screening and its clinical significance in residents in Iwate Prefecture : etiological relationship with metabolic syndrome
- Clinical evaluation of lamivudine therapy in patients with chronic hepatitis B based on a long-term outcome : Comparison with entecavir therapy
- Clinical evaluation of lamivudine therary in patients with chronic hepatitis B based on a long-term outcome : Comparison with entecavir therary
- 症例報告 Two patients with chronic hepatitis C who displayed a hypothyroidism during peginterferon therapy without clinical manifestations: Significance of negativity for thyroid-stimulation blocking antibody
- Serial changes of anti-HCV core titer in patients with chronic hepatitis C treated with peginterferon: a useful marker for outcome contributing to choice of an appropriate therapy